Home

Sharon Mates, Chairman, President & CEO: Intra-Cellular Therapies ITCI Sell · Filed 24/01/18

Trade details

Type
Insider sale
Amount
$4,437,087.75
Shares · price
65,979 sh · $67.25 a share
Held after
1,056,191 sh
Trade date
24/01/16
Filed
24/01/18
Days to filing
2 days

Sold 5.9% of holdings

Share of holding sold
5.9%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/12/17~24/02/15

Sharon Mates's recent trades

  • Sharon Mates

    Sell10b5-1 planIntra-Cellular Therapies

    $4.2M

    Filed 24/12/06

  • Sharon Mates

    Sell10b5-1 planIntra-Cellular Therapies

    $2.4M

    Filed 24/12/06

  • Sharon Mates

    Sell10b5-1 planIntra-Cellular Therapies

    $2M

    Filed 24/12/06

  • Sharon Mates

    Sell10b5-1 planIntra-Cellular Therapies

    $129.9K

    Filed 24/12/06

  • Sharon Mates

    Sell10b5-1 planIntra-Cellular Therapies

    $2.2M

    Filed 24/08/30

Sharon Mates, Chairman — sold $4.4M of Intra-Cellular Therapies ITCI · 5.9% of holdings · 10b5-1 plan | Whalegun